Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy have?
Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy has 342 citations in the OpenAlex counts ScholarIQ stores.
When was Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy published?
Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy has 2019 year in the ScholarIQ index.
What is the open-access status of Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy?
Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy has gold oa status in the ScholarIQ index.
What is the DOI of Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy?
The DOI for Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy is on the source record.
What is the PMID of Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy?
The PMID for Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy is on the source record.
What is the OpenAlex record for Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy?
The OpenAlex for Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy is on the source record.